Literature DB >> 15002819

Frequency of NOD2/CARD15 variants in both sporadic and familial cases of Crohn's disease across Italy. An Italian Group for Inflammatory Bowel Disease Study.

V Annese1, O Palmieri, A Latiano, S Ardizzone, F Castiglione, M Cottone, R D'Incà, P Gionchetti, C Papi, G Riegler, M Vecchi, A Andriulli.   

Abstract

BACKGROUND: Three variants of the NOD2/CARD15 gene are strongly associated with susceptibility to Crohn's disease; however, striking racial and geographic differences of their frequency have been described. AIMS: We have compared the allele frequencies of familial cases of Crohn's disease recruited in a multicentre study across Italy, in order to disclose possible geographic heterogeneity. Moreover, we also compared the allele frequencies in sporadic cases of Crohn's disease and healthy controls from Southern Italy with those reported in other two populations from Central and Northern Italy. SUBJECTS AND METHODS: A total of 731 subjects were genotyped for the polymorphism of three main variants (R702W, G908R and 1007 fs): 152 patients were familial cases of Crohn's disease, 183 were healthy first-degree relatives, 180 were sporadic cases of Crohn's disease, and 216 were unrelated healthy subjects.
RESULTS: The frequency of the frameshift mutation (1007 fs) was significantly higher in both familial and sporadic cases of Crohn's disease (P = 0.000001), and healthy first-degree relatives (P = 0.0001) compared to controls. At least one risk allele was found in 44% of familial Crohn's disease patients, compared to 7% of healthy controls (OR = 4; CI = 2-6.5). Two risk alleles were found in 14% of familial Crohn's disease, compared to less than 1% of controls (OR = 26: CI = 4-129).
CONCLUSIONS: Our data confirm the strong correlation between the 1007 fs variant and Crohn's disease, in both familial and sporadic cases. Moreover, no significant difference of allele frequencies was detected in familial cases, sporadic cases and healthy controls among different geographic areas of Italy.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15002819     DOI: 10.1016/j.dld.2003.10.010

Source DB:  PubMed          Journal:  Dig Liver Dis        ISSN: 1590-8658            Impact factor:   4.088


  7 in total

Review 1.  Host-microbiome interaction in Crohn's disease: A familiar or familial issue?

Authors:  Andrea Michielan; Renata D'Incà
Journal:  World J Gastrointest Pathophysiol       Date:  2015-11-15

Review 2.  Family and twin studies in inflammatory bowel disease.

Authors:  Leena Halme; Paulina Paavola-Sakki; Ulla Turunen; Maarit Lappalainen; Martti Farkkila; Kimmo Kontula
Journal:  World J Gastroenterol       Date:  2006-06-21       Impact factor: 5.742

3.  Distribution of common CARD15 variants in patients with sporadic Crohn's disease: cases from Turkey.

Authors:  F Aytül Uyar; Hülya Over-Hamzaoğlu; Filiz Türe; Ahmet Gül; Nurdan Tözün; Güher Saruhan-Direskeneli
Journal:  Dig Dis Sci       Date:  2006-04       Impact factor: 3.199

4.  Toll-like receptor 4 and NOD2/CARD15 mutations in Hungarian patients with Crohn's disease: phenotype-genotype correlations.

Authors:  Peter Laszlo Lakatos; Laszlo Lakatos; Ferenc Szalay; Claudia Willheim-Polli; Christoph Osterreicher; Zsolt Tulassay; Tamas Molnar; Walter Reinisch; Janos Papp; Gyula Mozsik; Peter Ferenci
Journal:  World J Gastroenterol       Date:  2005-03-14       Impact factor: 5.742

Review 5.  Associations between NOD2/CARD15 genotype and phenotype in Crohn's disease--Are we there yet?

Authors:  Graham Radford-Smith; Nirmala Pandeya
Journal:  World J Gastroenterol       Date:  2006-11-28       Impact factor: 5.742

6.  Incidence of Crohn's disease and CARD15 mutation in a small township in Sicily.

Authors:  M Cottone; M C Renda; A Mattaliano; L Oliva; W Fries; V Criscuoli; I Modesto; D Scimeca; A Maggio; A Casà; S Maisano; F Mocciaro; A Sferrazza; A Orlando
Journal:  Eur J Epidemiol       Date:  2006-12-08       Impact factor: 8.082

7.  Clinical significance of NOD2/CARD15 and Toll-like receptor 4 gene single nucleotide polymorphisms in inflammatory bowel disease.

Authors:  Luciana Rigoli; Claudio Romano; Rosario Alberto Caruso; Maria A Lo Presti; Chiara Di Bella; Vincenzo Procopio; Giuseppina Lo Giudice; Maria Amorini; Giuseppe Costantino; Maria D Sergi; Caterina Cuppari; Giovanna Elisa Calabro; Romina Gallizzi; Carmelo Damiano Salpietro; Walter Fries
Journal:  World J Gastroenterol       Date:  2008-07-28       Impact factor: 5.742

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.